Talis Biomedical Corporation (TLIS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Talis Biomedical Corporat...

    OTC: TLIS · Real-Time Price · USD
    1.06
    -0.54 (-33.75%)
    At close: Apr 04, 2025, 9:37 AM

    Talis Biomedical Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.22 -0.11 -0.48
    PEG Ratio
    		 0.00 0.00 0.01
    PS Ratio
    		 32.87 3.25 n/a
    PB Ratio
    		 0.20 0.09 0.39
    P/FCF Ratio
    		 -0.25 -0.12 -0.52
    P/OCF Ratio
    		 -0.25 -0.12 -0.53
    OCF/S Ratio
    		 -129.22 -27.42 n/a
    Debt / Equity Ratio
    		 0.28 0.26 0.06
    Quick Ratio
    		 8.86 10.52 12.36
    Current Ratio
    		 8.86 10.52 12.36
    Asset Turnover
    		 0.00 0.02 n/a
    Interest Coverage
    		 n/a n/a n/a
    Return on Equity
    		 n/a n/a n/a
    Return on Assets
    		 n/a n/a n/a
    Return on Invested Capital
    		 n/a n/a n/a
    Dividend Yield
    		 n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a
    Gross Profit Margin
    		 0.90 -1.3 n/a
    Net Profit Margin
    		 -150.5 -30.36 n/a
    Pretax Profit Margin
    		 -150.5 -30.95 n/a
    Operating Profit Margin
    		 -162.17 -31.53 n/a
    FCF Margin
    		 n/a n/a n/a
    EBITDA Margin
    		 -160.3 -29.11 n/a

    Add to Watchlist